Zhou, Sirui
Sosina, Olukayode A. http://orcid.org/0000-0003-2120-0338
Bovijn, Jonas
Laurent, Laetitia
Sharma, Vasundhara
Akbari, Parsa
Forgetta, Vincenzo
Jiang, Lai
Kosmicki, Jack A.
Banerjee, Nilanjana
Morris, John A. http://orcid.org/0000-0003-2769-8202
Oerton, Erin
Jones, Marcus
LeBlanc, Michelle G.
Idone, Vincent
Overton, John D.
Reid, Jeffrey G. http://orcid.org/0000-0001-8645-4713
Cantor, Michael http://orcid.org/0000-0002-1074-1203
Abecasis, Goncalo R. http://orcid.org/0000-0003-1509-1825
Goltzman, David http://orcid.org/0000-0003-3421-7147
Greenwood, Celia M. T. http://orcid.org/0000-0002-2427-5696
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Baras, Aris http://orcid.org/0000-0002-6830-3396
Economides, Aris N. http://orcid.org/0000-0002-6508-8942
Ferreira, Manuel A. R.
Hatsell, Sarah
Ohlsson, Claes http://orcid.org/0000-0002-9633-2805
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Lotta, Luca A.
,
Funding for this research was provided by:
Canadian Institutes of Health Research
This research received funding from Regeneron Pharmaceuticals Inc.
CIHR fellowship FRQS postdoctoral scholarship
Article History
Received: 8 February 2022
Accepted: 9 June 2023
First Online: 9 August 2023
Competing interests
: J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. He is the founder of 5 Prime Sciences (ExternalRef removed). Regeneron Genetics Center and Regeneron co-authors (O.A.S., J.B., P.A., J.A.K., N.B., M.J., M.G.L., V.I., J.D.O., J.G.R., M.C., G.R.A., A.B., A.N.E., M.A.R.F., S.H., L.A.L.) receive salary and own stocks or stock-options from Regeneron Pharmaceuticals Inc. This research received funding from Regeneron Pharmaceuticals Inc. E.O. is currently an employee at AstraZeneca. The remaining authors declare no competing interests.